Please note that the copy function is not enabled for this field.
If you wish to
modify
existing outcomes, please copy and paste the current outcome text into the Update field.
LOGIN
CREATE ACCOUNT
LOGIN
CREATE ACCOUNT
MY TRIALS
REGISTER TRIAL
FAQs
HINTS AND TIPS
DEFINITIONS
Trial Review
The ANZCTR website will be unavailable from 1pm until 3pm (AEDT) on Wednesday the 30th of October for website maintenance. Please be sure to log out of the system in order to avoid any loss of data.
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this
information for consumers
Download to PDF
Trial details imported from ClinicalTrials.gov
For full trial details, please see the original record at
https://clinicaltrials.gov/study/NCT02298088
Registration number
NCT02298088
Ethics application status
Date submitted
27/10/2014
Date registered
21/11/2014
Date last updated
15/02/2019
Titles & IDs
Public title
Ticagrelor in Patients With ST Elevation Myocardial Infarction Treated With Pharmacological Thrombolysis
Query!
Scientific title
Phase III, Randomized, International, Multicenter, Open Label, With Blinded Adjudication of Outcomes, Non-Inferiority Clinical Trial to Explore the Safety and Efficacy of Ticagrelor Compared With Clopidogrel in Patients With Acute Coronary Syndrome With ST Elevation Treated With Pharmacological Thrombolysis.
Query!
Secondary ID [1]
0
0
TREAT01
Query!
Universal Trial Number (UTN)
Query!
Trial acronym
TREAT
Query!
Linked study record
Query!
Health condition
Health condition(s) or problem(s) studied:
Acute ST Segment Elevation Myocardial Infarction
0
0
Query!
Thrombolysis in Myocardial Infarction Flow
0
0
Query!
Condition category
Condition code
Cardiovascular
0
0
0
0
Query!
Coronary heart disease
Query!
Cardiovascular
0
0
0
0
Query!
Other cardiovascular diseases
Query!
Intervention/exposure
Study type
Interventional
Query!
Description of intervention(s) / exposure
Treatment: Drugs - Ticagrelor 180 mg
Treatment: Drugs - Clopidogrel
Active comparator: Ticagrelor 180 mg - Patients assigned to Ticagrelor will receive oral Ticagrelor, 180 mg as early as possible after the index event and not \>24 h post event followed by 90 mg twice daily for 12 months.
Active comparator: Clopidogrel - Patients will take the 300 mg clopidogrel as early as possible after the index event and not \> 24h post event, followed by 75mg/day for 12 months.
For patients with \> 75 years the recommended load dose is 75 mg instead 300 mg.
Treatment: Drugs: Ticagrelor 180 mg
Ticagrelor, 180 mg as early as possible after the index event and not \>24 h post event followed by 90 mg twice daily for 12 months.
Treatment: Drugs: Clopidogrel
300 mg clopidogrel as early as possible after the index event and not \> 24h post event, followed by 75mg/day for 12 months.
For patients with \> 75 years the recommended load dose is 75 mg instead 300 mg.
Query!
Intervention code [1]
0
0
Treatment: Drugs
Query!
Comparator / control treatment
Query!
Control group
Query!
Outcomes
Primary outcome [1]
0
0
Safety Outcome as a measure of Time to TIMI-defined first major bleeding
Query!
Assessment method [1]
0
0
The primary safety endpoint is time to TIMI-defined and adjudicated first major bleeding event (including major life-threatening bleeding and other major bleeding).
Bleeding TIMI Definition
Major:
Any intracranial hemorrhage (ICH)\*, OR Clinically significant overt signs of hemorrhage associated with a drop in hemoglobin (Hgb) of = 5 g/dL (or, when Hgb is not available, an absolute drop in hematocrit (Hct) of = 15%).
An independent blinded central adjudication committee will adjudicate all suspected primary end points.
Query!
Timepoint [1]
0
0
30 days
Query!
Secondary outcome [1]
0
0
Efficacy Outcome as a measure of major cardiovascular events
Query!
Assessment method [1]
0
0
Secondary efficacy combined endpoint: death from vascular causes, myocardial infarction, stroke, severe recurrent ischemia, recurrent ischemia, TIA, or other arterial thrombotic event.
We will also measure the individual outcomes all-cause mortality and need for rescue PCI, as well as individual components of the combined efficacy endpoint.
Query!
Timepoint [1]
0
0
12 months
Query!
Secondary outcome [2]
0
0
Safety Outcome as a measure of bleeding event
Query!
Assessment method [2]
0
0
Secondary safety endpoints: Total bleeding (major and minor) according to PLATO, TIMI and BARC definitions, minor bleeding according to the TIMI definition and major bleeding as individual endpoint according to the PLATO definition. Others safety variables will include: dyspnea, arrhythmia, bradycardia and laboratory safety tests
Query!
Timepoint [2]
0
0
12 months
Query!
Eligibility
Key inclusion criteria
* Patients of both sexes aged = 18 years and < 75 years with ACS with ST segment elevation with onset during the previous 24 hours, documented by cardiac ischemic symptoms due to atherosclerosis of > 10 minutes duration at rest, treated with pharmacological thrombolysis
* Fibrinolytic therapy should be given to patients with STEMI and onset of ischemic symptoms within the previous 12 hours
Patients with acute coronary syndrome with ST segment elevation will be included provided they present ST segment elevation at the J point in two contiguous leads in electrocardiogram with cut-points: > 0.1mV in all leads other than leads V2-V3, where the following cut points apply: > 0.2 mV in men > 40 years; > 0.25 mV in men < 40 years, or >0.15 mV in women and at least 1 of the following criteria:
* Angina-like chest pain or ischemic equivalent chest pain;
* Abnormalities above the reference value for markers of myocardial necrosis (troponin and CK-MB).
The patient must be able to give informed consent in accordance with ICH GCP guidelines and local legislation and/or regulations.
Query!
Minimum age
18
Years
Query!
Query!
Maximum age
75
Years
Query!
Query!
Sex
Both males and females
Query!
Can healthy volunteers participate?
No
Query!
Key exclusion criteria
* Any contraindication against the use of clopidogrel (eg, hypersensitivity, moderate or severe liver disease, active bleeding or bleeding history, history of intracranial hemorrhage)
* Need for oral anticoagulation therapy,
* Concomitant oral or IV therapy with strong CYP3A inhibitors (ketoconazole, itraconazole, voriconazole, telithromycin, clarithromycin, nefazodone, ritonavir, saquinavir, nelfinavir, indinavir, atazanavir, grapefruit juice N1 L/d), CYP3A substrates with narrow therapeutic indices (cyclosporine, quinidine), or strong CYP3Ainducers (rifampin/rifampicin, phenytoin, carbamazepine)
* Increased risk of bradycardia events
* Dialysis required
* Known clinically important thrombocytopenia
* Known clinically important anemia
* Any other condition that may put the patient at risk or influence study results in the investigators' opinion (eg, cardiogenic shock, severe hemodynamic instability, active cancer)
* Participant in another investigational drug or device study within 30 d
* Pregnancy or lactation
* Any condition that increases the risk for noncompliance or being lost to follow-up
* Involvement in the planning or conduct of the study
* Previous enrollment or randomization in this study
* Contraindications to fibrinolytic therapy including: 15
* Any prior intracranial hemorrhage
* Known structural cerebral vascular lesion (eg, Arterial Venous Malformation - AVM)
* Known malignant intracranial neoplasm (primary or metastatic)
* Ischemic stroke within 3 months
* Suspected aortic dissection
* Active bleeding or bleeding diathesis (excluding menses)
* Significant closed head trauma or facial trauma within 3 months
Query!
Study design
Purpose of the study
Treatment
Query!
Allocation to intervention
Randomised controlled trial
Query!
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Query!
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Query!
Masking / blinding
Open (masking not used)
Query!
Who is / are masked / blinded?
Query!
Query!
Query!
Query!
Intervention assignment
Parallel
Query!
Other design features
Query!
Phase
Phase 3
Query!
Type of endpoint/s
Query!
Statistical methods / analysis
Query!
Recruitment
Recruitment status
Completed
Query!
Data analysis
Query!
Reason for early stopping/withdrawal
Query!
Other reasons
Query!
Date of first participant enrolment
Anticipated
Query!
Actual
1/08/2015
Query!
Date of last participant enrolment
Anticipated
Query!
Actual
Query!
Date of last data collection
Anticipated
Query!
Actual
1/01/2019
Query!
Sample size
Target
Query!
Accrual to date
Query!
Final
3799
Query!
Recruitment in Australia
Recruitment state(s)
Query!
Recruitment hospital [1]
0
0
Flinders Medical Centre - Adelaide
Query!
Recruitment hospital [2]
0
0
Royal Adelaide Hospital - Adelaide
Query!
Recruitment hospital [3]
0
0
Cairns Hospital - Cairns
Query!
Recruitment hospital [4]
0
0
The Alfred Hospital - Melbourne
Query!
Recruitment hospital [5]
0
0
Mildura Hospital - Mildura
Query!
Recruitment hospital [6]
0
0
John Hunter Hospital - Newcastle
Query!
Recruitment hospital [7]
0
0
Fiona Stanley Hospital - Perth
Query!
Recruitment hospital [8]
0
0
Liverpool Hospital - Sydney
Query!
Recruitment hospital [9]
0
0
Townsville Hospital - Townsville
Query!
Recruitment hospital [10]
0
0
Wollongong Hospital - Wollongong
Query!
Recruitment postcode(s) [1]
0
0
- Adelaide
Query!
Recruitment postcode(s) [2]
0
0
- Cairns
Query!
Recruitment postcode(s) [3]
0
0
- Melbourne
Query!
Recruitment postcode(s) [4]
0
0
- Mildura
Query!
Recruitment postcode(s) [5]
0
0
- Newcastle
Query!
Recruitment postcode(s) [6]
0
0
- Perth
Query!
Recruitment postcode(s) [7]
0
0
- Sydney
Query!
Recruitment postcode(s) [8]
0
0
- Townsville
Query!
Recruitment postcode(s) [9]
0
0
- Wollongong
Query!
Recruitment outside Australia
Country [1]
0
0
Argentina
Query!
State/province [1]
0
0
Bahia Blanca
Query!
Country [2]
0
0
Argentina
Query!
State/province [2]
0
0
Ciudad Autonoma de Buenos Aires
Query!
Country [3]
0
0
Argentina
Query!
State/province [3]
0
0
Florencio Varela
Query!
Country [4]
0
0
Argentina
Query!
State/province [4]
0
0
La Plata
Query!
Country [5]
0
0
Argentina
Query!
State/province [5]
0
0
Quilmes
Query!
Country [6]
0
0
Argentina
Query!
State/province [6]
0
0
San Miguel de Tucuman
Query!
Country [7]
0
0
Brazil
Query!
State/province [7]
0
0
Belo Horizonte
Query!
Country [8]
0
0
Brazil
Query!
State/province [8]
0
0
Brasília
Query!
Country [9]
0
0
Brazil
Query!
State/province [9]
0
0
Campinas
Query!
Country [10]
0
0
Brazil
Query!
State/province [10]
0
0
Ipiau
Query!
Country [11]
0
0
Brazil
Query!
State/province [11]
0
0
Manaus
Query!
Country [12]
0
0
Brazil
Query!
State/province [12]
0
0
Messejana
Query!
Country [13]
0
0
Brazil
Query!
State/province [13]
0
0
Montes Claros
Query!
Country [14]
0
0
Brazil
Query!
State/province [14]
0
0
Passo Fundo
Query!
Country [15]
0
0
Brazil
Query!
State/province [15]
0
0
Pocos de Caldas
Query!
Country [16]
0
0
Brazil
Query!
State/province [16]
0
0
Porto Alegre
Query!
Country [17]
0
0
Brazil
Query!
State/province [17]
0
0
Recife
Query!
Country [18]
0
0
Brazil
Query!
State/province [18]
0
0
Sao Caetano do Sul
Query!
Country [19]
0
0
Brazil
Query!
State/province [19]
0
0
Sao Jose do Rio Preto
Query!
Country [20]
0
0
Brazil
Query!
State/province [20]
0
0
Sao Paulo
Query!
Country [21]
0
0
Brazil
Query!
State/province [21]
0
0
Teresina
Query!
Country [22]
0
0
Canada
Query!
State/province [22]
0
0
Edmonton
Query!
Country [23]
0
0
Canada
Query!
State/province [23]
0
0
Halifax
Query!
Country [24]
0
0
Canada
Query!
State/province [24]
0
0
London
Query!
Country [25]
0
0
Canada
Query!
State/province [25]
0
0
Newmarket
Query!
Country [26]
0
0
Canada
Query!
State/province [26]
0
0
Ottawa
Query!
Country [27]
0
0
Canada
Query!
State/province [27]
0
0
Peterborough
Query!
Country [28]
0
0
Canada
Query!
State/province [28]
0
0
Quebec
Query!
Country [29]
0
0
Canada
Query!
State/province [29]
0
0
Regina
Query!
Country [30]
0
0
Canada
Query!
State/province [30]
0
0
Saint John
Query!
Country [31]
0
0
Canada
Query!
State/province [31]
0
0
Sherbrooke
Query!
Country [32]
0
0
Canada
Query!
State/province [32]
0
0
Thunder Bay
Query!
Country [33]
0
0
Canada
Query!
State/province [33]
0
0
Trois-Rivieres
Query!
Country [34]
0
0
Canada
Query!
State/province [34]
0
0
Victoria,
Query!
Country [35]
0
0
Canada
Query!
State/province [35]
0
0
Waterloo
Query!
Country [36]
0
0
Canada
Query!
State/province [36]
0
0
Windsor
Query!
Country [37]
0
0
Canada
Query!
State/province [37]
0
0
Winnipeg
Query!
Country [38]
0
0
China
Query!
State/province [38]
0
0
Alashan
Query!
Country [39]
0
0
China
Query!
State/province [39]
0
0
Anshan
Query!
Country [40]
0
0
China
Query!
State/province [40]
0
0
Baotou
Query!
Country [41]
0
0
China
Query!
State/province [41]
0
0
Bayan Nur
Query!
Country [42]
0
0
China
Query!
State/province [42]
0
0
Beijing
Query!
Country [43]
0
0
China
Query!
State/province [43]
0
0
Benxi
Query!
Country [44]
0
0
China
Query!
State/province [44]
0
0
Binzhou
Query!
Country [45]
0
0
China
Query!
State/province [45]
0
0
Changyuan
Query!
Country [46]
0
0
China
Query!
State/province [46]
0
0
Chaoyang
Query!
Country [47]
0
0
China
Query!
State/province [47]
0
0
Dengfeng
Query!
Country [48]
0
0
China
Query!
State/province [48]
0
0
Dunhua
Query!
Country [49]
0
0
China
Query!
State/province [49]
0
0
Fushun
Query!
Country [50]
0
0
China
Query!
State/province [50]
0
0
Gongyi
Query!
Country [51]
0
0
China
Query!
State/province [51]
0
0
Harbin
Query!
Country [52]
0
0
China
Query!
State/province [52]
0
0
Hebi
Query!
Country [53]
0
0
China
Query!
State/province [53]
0
0
Heze
Query!
Country [54]
0
0
China
Query!
State/province [54]
0
0
Hunchun
Query!
Country [55]
0
0
China
Query!
State/province [55]
0
0
Jiaozuo
Query!
Country [56]
0
0
China
Query!
State/province [56]
0
0
Laixi
Query!
Country [57]
0
0
China
Query!
State/province [57]
0
0
Liaocheng
Query!
Country [58]
0
0
China
Query!
State/province [58]
0
0
Liaoyang
Query!
Country [59]
0
0
China
Query!
State/province [59]
0
0
Liaoyuan
Query!
Country [60]
0
0
China
Query!
State/province [60]
0
0
Linfen
Query!
Country [61]
0
0
China
Query!
State/province [61]
0
0
Lingbao
Query!
Country [62]
0
0
China
Query!
State/province [62]
0
0
Luoyang
Query!
Country [63]
0
0
China
Query!
State/province [63]
0
0
Mengcheng
Query!
Country [64]
0
0
China
Query!
State/province [64]
0
0
Puyang
Query!
Country [65]
0
0
China
Query!
State/province [65]
0
0
Qinyang
Query!
Country [66]
0
0
China
Query!
State/province [66]
0
0
Sanmenxia
Query!
Country [67]
0
0
China
Query!
State/province [67]
0
0
Shangqiu
Query!
Country [68]
0
0
China
Query!
State/province [68]
0
0
Shenyang
Query!
Country [69]
0
0
China
Query!
State/province [69]
0
0
Shijiazhuang
Query!
Country [70]
0
0
China
Query!
State/province [70]
0
0
Tangshan
Query!
Country [71]
0
0
China
Query!
State/province [71]
0
0
Wuchuan
Query!
Country [72]
0
0
China
Query!
State/province [72]
0
0
Wuhai
Query!
Country [73]
0
0
China
Query!
State/province [73]
0
0
Wuhan
Query!
Country [74]
0
0
China
Query!
State/province [74]
0
0
Wuyishan
Query!
Country [75]
0
0
China
Query!
State/province [75]
0
0
Xining
Query!
Country [76]
0
0
China
Query!
State/province [76]
0
0
Xuzhou
Query!
Country [77]
0
0
China
Query!
State/province [77]
0
0
Yongcheng
Query!
Country [78]
0
0
China
Query!
State/province [78]
0
0
Yongzhou
Query!
Country [79]
0
0
China
Query!
State/province [79]
0
0
Yueyang
Query!
Country [80]
0
0
China
Query!
State/province [80]
0
0
Zhangye
Query!
Country [81]
0
0
China
Query!
State/province [81]
0
0
Zhoukou
Query!
Country [82]
0
0
Colombia
Query!
State/province [82]
0
0
Armenia
Query!
Country [83]
0
0
Colombia
Query!
State/province [83]
0
0
Cartagena
Query!
Country [84]
0
0
New Zealand
Query!
State/province [84]
0
0
Hastings
Query!
Country [85]
0
0
New Zealand
Query!
State/province [85]
0
0
Nelson
Query!
Country [86]
0
0
New Zealand
Query!
State/province [86]
0
0
New Plymouth
Query!
Country [87]
0
0
New Zealand
Query!
State/province [87]
0
0
Rotorua
Query!
Country [88]
0
0
New Zealand
Query!
State/province [88]
0
0
Tauranga
Query!
Country [89]
0
0
New Zealand
Query!
State/province [89]
0
0
Thames
Query!
Country [90]
0
0
New Zealand
Query!
State/province [90]
0
0
Whangarei
Query!
Country [91]
0
0
Peru
Query!
State/province [91]
0
0
Chiclayo
Query!
Country [92]
0
0
Peru
Query!
State/province [92]
0
0
Lima
Query!
Country [93]
0
0
Russian Federation
Query!
State/province [93]
0
0
Barnaul
Query!
Country [94]
0
0
Russian Federation
Query!
State/province [94]
0
0
Belgorod
Query!
Country [95]
0
0
Russian Federation
Query!
State/province [95]
0
0
Chelyabinsk
Query!
Country [96]
0
0
Russian Federation
Query!
State/province [96]
0
0
Gatchina
Query!
Country [97]
0
0
Russian Federation
Query!
State/province [97]
0
0
Irkutsk
Query!
Country [98]
0
0
Russian Federation
Query!
State/province [98]
0
0
Kirov
Query!
Country [99]
0
0
Russian Federation
Query!
State/province [99]
0
0
Krasnoyarsk
Query!
Country [100]
0
0
Russian Federation
Query!
State/province [100]
0
0
Lyubertsy
Query!
Country [101]
0
0
Russian Federation
Query!
State/province [101]
0
0
Murmansk
Query!
Country [102]
0
0
Russian Federation
Query!
State/province [102]
0
0
Novosibirsk
Query!
Country [103]
0
0
Russian Federation
Query!
State/province [103]
0
0
Pushchino
Query!
Country [104]
0
0
Russian Federation
Query!
State/province [104]
0
0
Rostov-on-Don
Query!
Country [105]
0
0
Russian Federation
Query!
State/province [105]
0
0
Ryazan
Query!
Country [106]
0
0
Russian Federation
Query!
State/province [106]
0
0
Smolensk
Query!
Country [107]
0
0
Russian Federation
Query!
State/province [107]
0
0
Tomsk
Query!
Country [108]
0
0
Russian Federation
Query!
State/province [108]
0
0
Tula
Query!
Country [109]
0
0
Russian Federation
Query!
State/province [109]
0
0
Tver
Query!
Country [110]
0
0
Russian Federation
Query!
State/province [110]
0
0
Vladimir
Query!
Country [111]
0
0
Russian Federation
Query!
State/province [111]
0
0
Voronezh
Query!
Country [112]
0
0
Russian Federation
Query!
State/province [112]
0
0
Yaroslavl
Query!
Country [113]
0
0
Ukraine
Query!
State/province [113]
0
0
Cherkasy
Query!
Country [114]
0
0
Ukraine
Query!
State/province [114]
0
0
Ivano-Frankivsk
Query!
Country [115]
0
0
Ukraine
Query!
State/province [115]
0
0
Kharkiv
Query!
Country [116]
0
0
Ukraine
Query!
State/province [116]
0
0
Kyiv
Query!
Country [117]
0
0
Ukraine
Query!
State/province [117]
0
0
Mykolaiv
Query!
Country [118]
0
0
Ukraine
Query!
State/province [118]
0
0
Odesa
Query!
Country [119]
0
0
Ukraine
Query!
State/province [119]
0
0
Rivne
Query!
Country [120]
0
0
Ukraine
Query!
State/province [120]
0
0
Sumy
Query!
Country [121]
0
0
Ukraine
Query!
State/province [121]
0
0
Zaporizhzhya
Query!
Country [122]
0
0
Ukraine
Query!
State/province [122]
0
0
Zhytomyr
Query!
Funding & Sponsors
Primary sponsor type
Other
Query!
Name
Hospital do Coracao
Query!
Address
Query!
Country
Query!
Ethics approval
Ethics application status
Query!
Summary
Brief summary
Administration of Ticagrelor in patients with ST elevation myocardial infarction treated with pharmacological thrombolysis
Query!
Trial website
https://clinicaltrials.gov/study/NCT02298088
Query!
Trial related presentations / publications
Cantor WJ, Tan M, Berwanger O, Lavi S, White HD, Nicolau JC, Dehghani P, Tajer CD, Lopes RD, Moia DDF, Nicholls SJ, Parkhomenko A, Averkov O, Brass N, Lutchmedial S, Malaga G, Damiani LP, Piegas LS, Granger CB, Goodman SG. Morphine and clinical outcomes in patients with ST segment elevation myocardial infarction treated with fibrinolytic and antiplatelet therapy: Insights from the TREAT trial. Am Heart J. 2022 Sep;251:1-12. doi: 10.1016/j.ahj.2022.05.005. Epub 2022 May 6. Berwanger O, Lopes RD, Moia DDF, Fonseca FA, Jiang L, Goodman SG, Nicholls SJ, Parkhomenko A, Averkov O, Tajer C, Malaga G, Saraiva JFK, Guimaraes HP, de Barros E Silva PGM, Damiani LP, Santos RHN, Paisani DM, Miranda TA, Valeis N, Piegas LS, Granger CB, White HD, Nicolau JC. Ticagrelor Versus Clopidogrel in Patients With STEMI Treated With Fibrinolysis: TREAT Trial. J Am Coll Cardiol. 2019 Jun 11;73(22):2819-2828. doi: 10.1016/j.jacc.2019.03.011. Epub 2019 Mar 18. Berwanger O, Nicolau JC, Carvalho AC, Jiang L, Goodman SG, Nicholls SJ, Parkhomenko A, Averkov O, Tajer C, Malaga G, Saraiva JFK, Fonseca FA, De Luca FA, Guimaraes HP, de Barros E Silva PGM, Damiani LP, Paisani DM, Lasagno CMR, Candido CT, Valeis N, Moia DDF, Piegas LS, Granger CB, White HD, Lopes RD; TREAT Study Group. Ticagrelor vs Clopidogrel After Fibrinolytic Therapy in Patients With ST-Elevation Myocardial Infarction: A Randomized Clinical Trial. JAMA Cardiol. 2018 May 1;3(5):391-399. doi: 10.1001/jamacardio.2018.0612. Erratum In: JAMA Cardiol. 2018 May 1;3(5):445. doi: 10.1001/jamacardio.2018.1067.
Query!
Public notes
Query!
Contacts
Principal investigator
Name
0
0
Otavio Berwanger, MD,PhD
Query!
Address
0
0
Hospital do Coracao
Query!
Country
0
0
Query!
Phone
0
0
Query!
Fax
0
0
Query!
Email
0
0
Query!
Contact person for public queries
Name
0
0
Query!
Address
0
0
Query!
Country
0
0
Query!
Phone
0
0
Query!
Fax
0
0
Query!
Email
0
0
Query!
Contact person for scientific queries
No information has been provided regarding IPD availability
What supporting documents are/will be available?
No Supporting Document Provided
Results publications and other study-related documents
No documents have been uploaded by study researchers.
Results not provided in
https://clinicaltrials.gov/study/NCT02298088
Download to PDF